COVID-19 Vaccine Distribution Challenges Highlighted in Recent Study

Strategic Insights -

Researchers at Oak Ridge National Laboratory have identified key challenges in the distribution of COVID-19 vaccines, particularly in regards to ultra-low temperature storage and transportation. The study highlights the need for a secure, safe, and effective solution to overcome these challenges, which include the requirement for specialized refrigeration equipment and limited infrastructure in rural or suburban areas. The study proposes an innovative solution utilizing commercially available refrigeration container units to meet the vaccine storage temperature requirement.

Key Takeaways:

  • The Pfizer vaccine requires ultra-low temperature storage between -80 degrees C and -60 degrees C, while the Moderna vaccine requires -30 degrees C storage.
  • The last stage of distribution is challenging, especially for rural or suburban areas, due to limited infrastructure and specialized refrigeration equipment.
  • The need for a large amount of ultra-low temperature refrigeration equipment creates tremendous pressure on suppliers.
  • Limited data is available to address ancillary challenges of the distribution framework for both transportation and storage stages.
  • The study proposes an effective, secure, and safe ultra-low temperature refrigeration solution to resolve the vaccine distribution last mile challenge.
  • The solution utilizes commercially available refrigeration container units, which can be retrofitted to meet the vaccine storage temperature requirement.
  • Experimental and simulation studies are conducted to evaluate the technical merits of this solution with the ability to control temperature at -30 degrees C or -70 degrees C as part of the last mile supply chain for vaccine candidates.

Statistics:

  • The Pfizer vaccine requires ultra-low temperature storage between -80 degrees C and -60 degrees C.
  • The Moderna vaccine requires -30 degrees C storage.
  • The study proposes an effective, secure, and safe ultra-low temperature refrigeration solution to resolve the vaccine distribution last mile challenge.
  • The solution utilizes commercially available refrigeration container units, which can be retrofitted to meet the vaccine storage temperature requirement.

Sources:

  • O.R. National Lab. (2022). Covid 19 Vaccine Distribution Solution To the Last Mile Challenge: Experimental and Simulation Studies of Ultra-low Temperature Refrigeration System. International Journal of Refrigeration, 133, 313-325.
  • Data detailed on Coronavirus - COVID-19 have been presented.
  • NewsRx. (2022, January 12). Reports Summarize COVID-19 Study Results from Oak Ridge National Laboratory. Vaccine Weekly, 604.